MBD2 and cancer: Methylases and demethylases of m6A can affect the complexity of cancer progression (Zhang et al., 2017b; Weng et al., 2018; Huang et al., 2019; Li J et al., 2020), thus SUMOylation of remaining enzymes should be investigated for potential clinical application of cancer treatment.